Fol. Biol. 2008, 54, 162-167
https://doi.org/10.14712/fb2008054050162
A Novel Method for the Estimation of Podocyte Injury: Podocalyxin-Positive Elements in Urine
References
1. 2006) Parietal podocytes in normal human glomeruli. J. Am. Soc. Nephrol. 17, 2770-2780.
< , J., Mandet, Ch., Hill, G. S., Bruneval P. (https://doi.org/10.1681/ASN.2006040325>
2. 2007) A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin. J. Am. Soc. Nephrol. 2, 529-542.
< , L., Schnaper, H. W., Kopp, J. B. (https://doi.org/10.2215/CJN.04121206>
3. 2004) Enhanced podocalyxin expression alters the structure of podocyte basal surface. J. Cell Sci. 117, 3281-3294.
< , C. G., Kitsiou, P. V., Tzinia, A. K., Panagopoulou, E., Marinos, E., Kershaw, D. B., Kerjaschki, D., Tsilibary, E. C. (https://doi.org/10.1242/jcs.01163>
4. 1995) Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis. Nephron 69, 397-403.
< , M., Yamamoto, T., Yanagihara, T., Takada, T., Itoh, M., Adachi, Y., Yoshizumi, A., Kawasaki, K., Kihara, I. (https://doi.org/10.1159/000188509>
5. 2001) Urinary podocytes in primary focal segmental glomerulosclerosis. Nephron 89, 342-347.
< , M., Yanagihara, T., Kihara, I. (https://doi.org/10.1159/000046097>
6. 2005) Apical cell membranes are shed into urine from injured podocytes: A novel phenomenon of podocyte injury. J. Am. Soc. Nephrol. 16, 408-416.
< , M., Yanagihara, T., Kihara, I., Higashi, K., Fujimoto, K., Kajita, T. (https://doi.org/10.1681/ASN.2004070564>
7. 2003) Urinary sediment podocalyxin in children with glomerular disease. Nephron Clin. Pract. 95, 91-99.
< , K., Kawachi, H., Uchida, Y., Hara, M., Shimizu, F., Uchiyama, M. (https://doi.org/10.1159/000074322>
8. 2002) Preservation of urine for flow cytometric and visual microscopic testing. Clin. Chem. 48, 900-905.
< , T., Vuotari, L., Pohjavaara, S., Laippala, P. (https://doi.org/10.1093/clinchem/48.6.900>
9. 2007) An introduction to biomarkers: applications to chronic kidney disease. Pediatr. Nephrol. 22, 1849-1859.
< , K. V. (https://doi.org/10.1007/s00467-007-0455-9>
10. 2002) Podocyte biology and response to injury. J. Am. Soc. Nephrol. 13, 3005-3015.
< , P., Shankland, S. J. (https://doi.org/10.1097/01.ASN.0000039661.06947.FD>
11. 2007) Podocyte damage resulting in podocyturia: a potential diagnostic marker to assess glomerular disease activity. Nephron Clin. Pract. 106, c61-c66.
< , A., Floege, J. (https://doi.org/10.1159/000101799>
12. 1999) Complement (C5b-9) induces glomerular epithelial cell DNA synthesis but not proliferation in vitro. Kidney Int. 56, 538-548.
< , S. J., Pippin, J. W., Couser, W. G. (https://doi.org/10.1046/j.1523-1755.1999.00560.x>
13. 2004) Overexpresion of the anti-adhesin podocalyxin is an independent predictor of breast cancer progresion. Cancer Res. 64, 5068-5073.
< , A., Nielsen, J. S., Makretsov, N., McCoy, M. L., Prentice, L., Gliks, C. B., Chia, S. K., Gelmon, K. A., Kershaw, D. B., Hunstamn, D. G., McNagny, K. M., Roskelley, C. D. (https://doi.org/10.1158/0008-5472.CAN-04-0240>
14. 2005) Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J. Am. Soc. Nephrol. 16, 1733-1741.
< , D., Petermann, A., Kunter, U., Rong, Shankland, S. J., Floege, J. (https://doi.org/10.1681/ASN.2005020159>